The Middle EAST Achromatopsia Treatment Market was valued at USD 0.15 billion in 2024 and is projected to reach USD 0.45 billion by 2034, registering a CAGR of 11.5%. This growth trajectory is underpinned by increasing awareness of achromatopsia, a hereditary condition characterized by the absence of color vision, which is driving demand for effective treatment options. The rising prevalence of...